Physician

Jorge G Arroyo, M.D., MPH

According to 2025 Medicare claims, Jorge Arroyo, M.D., MPH (NPI: 1942248257) practices ophthalmology in the Cambridge-Newton-Framingham, MA market, with the plurality of this provider's patient population coming from Middlesex, MA. This provider's primary affiliated billing organization is BOSTON VISION NETWORK ONE (NPI: 1679228738; TIN: 874650942) and primary practice location at 01757-1754. Arroyo is affiliated with the Lahey Clinical Performance ACO (ACO ID: A1490), participating under the MSSP model.

Arroyo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,286 traditional Medicare patients, billed 11,649 HCPCS/CPT codes, and received $1,311,106 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 152 prescription claims across 53 beneficiaries totaling $5,735 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 16 records totaling $1,555. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $546,594 to $1,311,106. In contrast, Part D prescription costs have fallen sharply in recent years, from $10,858 to $5,735. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$656K$1.3M2015 Medicare payment: $546,594 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $423,008 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $408,171 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $352,266 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $335,552 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $255,741 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $213,496 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $280,200 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,311,106 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156994,360$546,594
20166424,679$423,008
20176004,725$408,171
20185724,840$352,266
20195414,370$335,552
20204232,864$255,741
20214082,813$213,496
2022N/RN/RN/R
20233652,514$280,200
20241,28611,649$1,311,106

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$12K$23K2015 Drug cost: $10,858 (USD; Tot_Drug_Cst)2016 Drug cost: $15,038 (USD; Tot_Drug_Cst)2017 Drug cost: $18,703 (USD; Tot_Drug_Cst)2018 Drug cost: $20,155 (USD; Tot_Drug_Cst)2019 Drug cost: $23,108 (USD; Tot_Drug_Cst)2020 Drug cost: $13,636 (USD; Tot_Drug_Cst)2021 Drug cost: $15,142 (USD; Tot_Drug_Cst)2022 Drug cost: $1,930 (USD; Tot_Drug_Cst)2023 Drug cost: $1,757 (USD; Tot_Drug_Cst)2024 Drug cost: $5,735 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201569165$10,858
2016108281$15,038
2017124367$18,703
2018129332$20,155
2019123358$23,108
202081286$13,636
202183270$15,142
20221637$1,930
20231949$1,757
202453152$5,735

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye2941,229$99
92014Established patient complete exam of visual system1,2091,611$97
J9035Injection, bevacizumab, 10 mg178740$56
92134Imaging of retina1,1602,422$33
92201Extended exam of the back part of the eye with retinal drawing245270$18

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate492,020$2,572
Ketorolac TromethamineKetorolac Tromethamine531,825$1,152
Timolol MaleateTimolol Maleate11594$249
Dorzolamide HclDorzolamide Hcl11580$198

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.16$1,555Dutch Ophthalmic, USA
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jorge G. Arroyo, M.D., MPH?

Tedicare shows public-source Medicare data for Jorge G. Arroyo, M.D., MPH (NPI 1942248257), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jorge G. Arroyo, M.D., MPH have ACO affiliation data?

Jorge G. Arroyo, M.D., MPH is shown with ACO affiliation data for Lahey Clinical Performance ACO (MSSP, ACO ID A1490).

What billing organization is linked to Jorge G. Arroyo, M.D., MPH?

Jorge G. Arroyo, M.D., MPH is linked to BOSTON VISION NETWORK ONE (billing NPI 1679228738) in the available physician profile data.

Does Jorge G. Arroyo, M.D., MPH have Open Payments data?

Jorge G. Arroyo, M.D., MPH has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.